American Cannabis Company, Inc. (AMMJ)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
American Cannabis Company, Inc. (AMMJ) trades at $0.00 with AI Score 41/100 (Grade C). American Cannabis Company, Inc. provides consulting services and products to businesses in the regulated cannabis and hemp industries in the United States and Canada. Market cap: $130,061, Sector: Industrials.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for AMMJ: AMMJ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMMJ against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AMMJ: the 1 perspectives are evenly split.
How is this calculated? →American Cannabis Company, Inc. (AMMJ) Industrial Operations Profile
American Cannabis Company, Inc. offers consulting and product solutions for the cannabis and hemp industries, providing services from business planning to regulatory compliance, and selling cultivation equipment like the Satchel and SoHum Living Soil. The company operates in the US and Canada.
What Is the Investment Thesis for AMMJ?
American Cannabis Company, Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's consulting services and product offerings cater to a niche market, providing potential for growth as the cannabis industry expands. However, the company's small size, as indicated by its 130K market cap and negative profit margin of -147.8%, suggests significant financial risks. The negative beta of -1.70 indicates an inverse correlation with the market, which may offer some diversification benefits but also reflects the company's unique risk profile. Investors should carefully consider the company's financial standing and the competitive landscape before investing. Key catalysts include the expansion of cannabis legalization and the successful adoption of their cultivation products.
Based on FMP financials and quantitative analysis
AMMJ Key Highlights
- Market Cap of 130K indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.01 reflects the company's current lack of profitability.
- Profit Margin of -147.8% highlights significant challenges in achieving profitability.
- Gross Margin of 42.1% suggests a solid foundation for profitability if operational efficiencies improve.
- Negative Beta of -1.70 indicates an inverse correlation with the market, potentially offering diversification benefits.
Who Are AMMJ's Competitors?
AMMJ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GLAI Global AI, Inc. | $0.60 | +2.84% | $92.39M | 65 |
| YJGJ Yijia Group Corp. | $4.83 | +0.00% | $40.26M | 64 |
| ROMA Roma Green Finance Limited | $8.58 | +6.58% | $511.06M | 61 |
| NORD Nordicus Partners Corporation | $2.74 | +11.84% | $51.75M | 60 |
| GLCP Global Leaders Corp | $1.00 | +0.00% | $154.39M | 44 |
| RGP Resources Connection, Inc. | $4.64 | +0.43% | $159.29M | 44 |
| SDH Global Internet of People, Inc. | $2.16 | +0.47% | $52.98M | 45 |
| CRWE Crown Equity Holdings Inc. | $0.43 | +0.05% | $6.86M | 45 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AMMJ's Key Strengths?
- Specialized expertise in the cannabis and hemp industries.
- Proprietary products for cultivation and processing.
- Comprehensive consulting services covering various stages of business development.
- Strategic partnerships within the cannabis industry.
What Are AMMJ's Weaknesses?
- Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Limited number of employees.
- Dependence on the evolving regulatory landscape of the cannabis industry.
What Could Drive AMMJ Stock Higher?
- Expansion of cannabis legalization in additional states and countries, increasing demand for consulting services.
- Development and launch of new products for cannabis cultivation and processing.
- Strategic partnerships and acquisitions to expand service offerings and market reach.
What Are the Key Risks for AMMJ?
- Financial-distress signal — its Altman Z-Score of -15.83 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Increasing competition from larger consulting firms and cannabis companies.
- Evolving regulations and potential changes in cannabis laws.
- Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Negative perceptions and social stigma associated with cannabis.
What Are the Growth Opportunities for AMMJ?
- Expansion of Consulting Services: The increasing legalization of cannabis in more states and countries presents a significant opportunity for American Cannabis Company to expand its consulting services. By offering expertise in licensing, regulatory compliance, and business planning, the company can attract new clients entering the cannabis market. The market for cannabis consulting services is projected to grow as more jurisdictions legalize cannabis, offering a substantial revenue opportunity for AMMJ.
- Product Innovation and Development: Investing in research and development to create innovative products for cannabis cultivation and processing can drive growth. Developing proprietary technologies or unique solutions can differentiate American Cannabis Company from competitors and attract customers seeking cutting-edge solutions. The market for cannabis cultivation equipment is expected to expand, providing a favorable environment for product innovation.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the cannabis industry can expand American Cannabis Company's reach and service offerings. Acquiring complementary businesses can also provide access to new markets and technologies. These partnerships can create synergies and enhance the company's competitive position.
- International Expansion: As cannabis legalization spreads globally, American Cannabis Company can explore opportunities to expand its operations into new international markets. Offering consulting services and products tailored to the specific regulatory environments of different countries can drive growth and diversify revenue streams. This expansion requires careful consideration of local laws and regulations.
- Focus on Hemp Industry: With the growing demand for hemp-derived products, American Cannabis Company can capitalize on this trend by offering specialized consulting services and products for hemp cultivation and processing. The hemp industry presents a significant growth opportunity, particularly in areas such as CBD production and industrial hemp applications. Focusing on this sector can diversify the company's revenue streams and reduce its reliance on the cannabis market.
What Opportunities Does AMMJ Have?
- Expansion into new geographic markets as cannabis legalization spreads.
- Development of innovative products and technologies for cannabis cultivation.
- Strategic acquisitions and partnerships to expand service offerings.
- Growing demand for hemp-derived products and services.
What Threats Does AMMJ Face?
- Increasing competition from larger consulting firms and cannabis companies.
- Evolving regulations and potential changes in cannabis laws.
- Economic downturns and reduced investment in the cannabis industry.
- Negative perceptions and social stigma associated with cannabis.
What Are AMMJ's Competitive Advantages?
- Specialized Expertise: Deep understanding of the cannabis and hemp industries, providing valuable insights and guidance to clients.
- Proprietary Products: Unique products like The Satchel and SoHum Living Soil offer a competitive advantage.
- Regulatory Knowledge: Expertise in navigating the complex regulatory landscape of the cannabis industry.
- Established Partnerships: Strategic partnerships with other companies in the industry enhance service offerings and market reach.
What Does AMMJ Do?
Founded in 2013, American Cannabis Company, Inc. provides solutions for businesses operating within the regulated cannabis industry across the United States and Canada. The company, along with its subsidiary Hollister & Blacksmith, Inc., offers a suite of consulting services tailored to cannabis and hemp businesses at various stages of development. These services encompass business planning, license application support, growth strategy development, and ongoing monitoring. Additionally, American Cannabis Company provides cultivation build-out oversight, cannabis regulatory compliance assistance, and compliance audit services. Beyond consulting, American Cannabis Company sells products and equipment essential for cannabis cultivation, processing, transportation, and retail. Key products include The Satchel, a child-proof exit package; SoHum Living Soil, a just-add-water soil solution; the High Density Cultivation System, designed for efficient space utilization; and The Cultivation Cube, a scalable cultivation system. The company also offers advisory services for designing industry-specific products and facilities, and manages a strategic partnership offering commonly used customer products.
What Products and Services Does AMMJ Offer?
- Provides consulting services for cannabis and hemp businesses.
- Assists with cannabis and hemp business planning.
- Supports license applications for cannabis businesses.
- Develops growth strategies for cannabis companies.
- Offers cultivation build-out oversight services.
- Provides cannabis regulatory compliance and audit services.
- Sells products and equipment for cannabis cultivation and processing.
- Offers advisory services for designing industry-specific products and facilities.
How Does AMMJ Make Money?
- Generates revenue through consulting fees for services provided to cannabis and hemp businesses.
- Sells cultivation products and equipment, such as The Satchel and SoHum Living Soil.
- Offers advisory services for designing industry-specific products and facilities.
- Manages a strategic group partnership that offers customer products commonly used in the industry.
What Industry Does AMMJ Operate In?
American Cannabis Company operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance. The market is becoming increasingly competitive, with numerous companies offering similar consulting services and cultivation products. The company's success depends on its ability to differentiate itself through specialized expertise, innovative products, and effective marketing. The industry is subject to evolving regulations, creating both opportunities and challenges for companies like American Cannabis Company.
Who Are AMMJ's Key Customers?
- Cannabis cultivators and growers.
- Cannabis processors and manufacturers.
- Cannabis dispensaries and retailers.
- Hemp farmers and processors.
F-Score 2/9Financial Health
American Cannabis Company, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -15.83 places it in the distress zone, a signal of elevated financial risk.
Quarterly Financial Performance: American Cannabis Company, Inc.
Revenue for American Cannabis Company, Inc. came in at $432K during Q2 2024, a 68.8% improvement versus the preceding quarter. The company recorded a net loss of $636K, with diluted EPS of $-0.00.
AMMJ Valuation & Market Position
With a 130K market cap, American Cannabis Company, Inc. sits in the micro-cap segment of the market. Relative to its peer group, AMMJ's quantitative score of 41/100 is below the peer average of 59/100.
Key Financial Metrics
Its free cash flow yield is -88.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.42 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
American Cannabis Company, Inc. operates in the Consulting Services industry within the Industrials sector. It is headquartered in Colorado Springs, US. The company is led by CEO Joseph Cleghorn. AMMJ has traded publicly since 2014.
AMMJ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized expertise in the cannabis and hemp industries.
- Proprietary products for cultivation and processing.
- Comprehensive consulting services covering various stages of business development.
- Strategic partnerships within the cannabis industry.
Bear Case
- Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Limited number of employees.
- Dependence on the evolving regulatory landscape of the cannabis industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2024 | $431,878 | -$636,000 | -$0.0034 |
| Q1 2024 | $255,821 | -$132,551 | -$0.0007 |
Based on FMP financials and quantitative analysis
AMMJ Latest News
No recent news available for AMMJ.
AMMJ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMMJ.
Price Targets
Wall Street price target analysis for AMMJ.
AMMJ MoonshotScore
What does this score mean?
The MoonshotScore rates AMMJ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Consulting ServicesLeadership: Joseph Cleghorn
CEO
Joseph Cleghorn serves as the CEO of American Cannabis Company, Inc. His background includes experience in business management and strategic development within emerging industries. He has focused on building the company's consulting services and product offerings to meet the needs of the regulated cannabis industry. His leadership is centered on innovation and compliance within the evolving cannabis market.
Track Record: Under Joseph Cleghorn's leadership, American Cannabis Company has focused on providing comprehensive solutions for cannabis businesses. Key achievements include the development of proprietary products like The Satchel and SoHum Living Soil. Strategic decisions have centered on expanding the company's consulting services and navigating the complex regulatory landscape of the cannabis industry. The company manages a small team of 4 employees.
AMMJ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that American Cannabis Company may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. This tier is often associated with higher risk and greater potential for volatility compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: OTC companies often have less stringent reporting requirements, making it difficult to assess their financial health.
- Liquidity Risk: Lower trading volumes can lead to wider bid-ask spreads and difficulty in executing trades.
- Regulatory Scrutiny: OTC markets are subject to less regulatory oversight, increasing the risk of fraud and manipulation.
- Going Concern Risk: Companies trading on the OTC Other tier may face financial difficulties and potential bankruptcy.
- Valuation Uncertainty: Limited information and liquidity can make it challenging to accurately value OTC stocks.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory actions or legal issues involving the company.
- Company has been in operation since 2013.
- Provides consulting services and products to the regulated cannabis industry.
- Has a subsidiary, Hollister & Blacksmith, Inc.
- Offers a range of products and services, including The Satchel and SoHum Living Soil.
- CEO is identified as Joseph Cleghorn.
American Cannabis Company, Inc. Industrials Stock: Key Questions Answered
What does American Cannabis Company, Inc. do?
American Cannabis Company, Inc. provides consulting services and products to businesses operating in the regulated cannabis and hemp industries in the United States and Canada. The company offers services such as business planning, license application support, growth strategies, regulatory compliance, and cultivation build-out oversight. It also sells products and equipment used in cannabis cultivation, processing, transportation, and retail, including The Satchel, SoHum Living Soil, and the High Density Cultivation System. The company aims to provide comprehensive solutions for businesses in the cannabis and hemp sectors.
What are the main risks for AMMJ?
American Cannabis Company, Inc. faces several risks, including its small market capitalization, negative profit margin, and dependence on the evolving regulatory landscape of the cannabis industry. Increasing competition from larger consulting firms and cannabis companies poses a threat to its market share. Changes in cannabis laws and regulations could negatively impact its business. As an OTC stock, AMMJ is subject to liquidity risk and limited financial disclosure, making it difficult to assess its financial health and operational performance. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for AMMJ?
American Cannabis Company, Inc. (AMMJ) holds an AI score of 41/100 (low). Not financial advice.
How frequently does AMMJ data refresh on this page?
AMMJ prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AMMJ's recent stock price performance?
American Cannabis Company, Inc. (AMMJ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in the cannabis and hemp industries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AMMJ overvalued or undervalued right now?
Valuing American Cannabis Company, Inc. (AMMJ) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AMMJ?
Before investing in American Cannabis Company, Inc. (AMMJ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding AMMJ to a portfolio?
Key strength of American Cannabis Company, Inc. (AMMJ): Specialized expertise in the cannabis and hemp industries. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market investments carry significant risk.
- AI analysis is pending and may provide further insights.